Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Notes Payables (2016 - 2022)

Historic Notes Payables for CV Sciences (CVSI) over the last 9 years, with Q2 2022 value amounting to $952000.0.

  • CV Sciences' Notes Payables fell 6824.55% to $952000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $952000.0, marking a year-over-year decrease of 6824.55%. This contributed to the annual value of $612000.0 for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q2 2022, CV Sciences' Notes Payables is $952000.0, which was down 6824.55% from $1.0 million recorded in Q1 2022.
  • Over the past 5 years, CV Sciences' Notes Payables peaked at $3.0 million during Q2 2021, and registered a low of $66883.0 during Q1 2018.
  • Moreover, its 5-year median value for Notes Payables was $612000.0 (2021), whereas its average is $965245.5.
  • Its Notes Payables has fluctuated over the past 5 years, first skyrocketed by 466352.15% in 2018, then tumbled by 9203.99% in 2019.
  • Quarter analysis of 5 years shows CV Sciences' Notes Payables stood at $474000.0 in 2018, then tumbled by 85.44% to $69000.0 in 2019, then skyrocketed by 426.09% to $363000.0 in 2020, then skyrocketed by 68.6% to $612000.0 in 2021, then soared by 55.56% to $952000.0 in 2022.
  • Its Notes Payables was $952000.0 in Q2 2022, compared to $1.0 million in Q1 2022 and $612000.0 in Q4 2021.